This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.

Insights & Events

Filter

Content Type

Format

Service

Industry

Date

Showing 1-12 of 331 Search Results

Life Sciences

The end of high drug prices? Exploring the potential and limits of PDABs
- CRA Insights
- July 2024
Life Sciences

Ethics of artificial intelligence in the life sciences industry
- Podcast
- July 9, 2024
Life Sciences

ASCO 2024 review: The benefits and barriers of biomarkers in oncology
- CRA Insights
- June 25, 2024
Life Sciences

Quantifying public and private investment in European biopharmaceutical research and development
- Articles
- June 2024
Life Sciences

Payer value demonstration—The evolving role of health economics and outcomes research (HEOR)
- CRA Insights
- June 2024
Life Sciences

Time from EMA approval to CT outcome for first indication vs. AMSR
- Infographics
- May 29, 2024
Life Sciences Litigation

Best practices in the use of damages experts in complex commercial arbitrations
- Books
- May 22, 2024
Life Sciences

Impact of Medicare Price “Negotiation” Program on small and large molecule medicines
- Reports
- May 2024
Life Sciences

Assessment of the impact of earlier access to disease-modifying treatments with more convenient administration frequency in reducing the socioeconomic burden for multiple sclerosis patients in Europe
- Reports
- May 13, 2024
Life Sciences

An analysis of Medicaid CPI rebates and the sustainability of US generic markets
- Reports
- May 2024
Life Sciences

Navigating payer challenges in rare disease
- Infographics
- April 19, 2024
Market Research in Life Sciences

Access solutions: Reconciling potential for improved patient access with implementation realities
- CRA Insights
- March 14, 2024